Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
0.6596
-0.0005 (-0.08%)
Sep 12, 2025, 4:00 PM EDT - Market closed

Can-Fite BioPharma Stock Forecast

CANF's stock price has decreased by -71.32% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts that cover Can-Fite BioPharma stock have a consensus rating of "Strong Buy" and an average price target of $14.5, which forecasts a 2,098.30% increase in the stock price over the next year. The lowest target is $11 and the highest is $18.

Price Target: $14.5 (+2,098.30%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$11$14.5$18$18
Change+1567.7%+2098.3%+2628.9%+2628.9%

Analyst Ratings

The average analyst rating for Can-Fite BioPharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy222222
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$11
Strong BuyMaintains$11+1,567.68%Sep 2, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$10
Strong BuyMaintains$10+1,416.07%Jul 29, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$10
Strong BuyMaintains$10+1,416.07%Apr 15, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$10
Strong BuyMaintains$10+1,416.07%Mar 21, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$10
Strong BuyMaintains$10+1,416.07%Mar 20, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
3.79M
from 674.00K
Increased by 461.72%
Revenue Next Year
3.00M
from 3.79M
Decreased by -20.66%
EPS This Year
-4.20
from -0.00
EPS Next Year
1.29
from -4.20
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
763.00K853.00K810.00K743.00K674.00K3.79M3.00M
Revenue Growth
-62.45%11.80%-5.04%-8.27%-9.29%461.72%-20.66%
EPS
-0.04-0.03-0.01-0.01-0.00-4.201.29
EPS Growth
-------
Forward PE
------0.51
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High3.9M3.1M
Avg3.8M3.0M
Low3.6M2.9M

Revenue Growth

Revenue Growth202520262027
High
478.2%
-18.3%
Avg
461.7%
-20.7%
Low
439.6%
-23.8%

EPS Forecast

EPS20252026
High-4.331.32
Avg-4.201.29
Low-4.041.23

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.